Tag Archives: epilepsy medication

Drug-Resistant and Undertreated Epilepsy (sponsored by LivaNova)

November 27, 2024Episodesepilepsy, epilepsy medication, epilepsy research, medications, seizurestsc-now

In honor of National Epilepsy Awareness Month, TSC Now host Dan Klein is joined by Steven Wolf, MD, Director at the TSC Clinic Without Walls serving NYC, Westchester, Hudson Valley & Connecticut. Dr. Wolf also serves as the Director of Pediatric Epilepsy at Boston Children’s Health Physicians of New York and Connecticut. Dr. Wolf specializes in child neurology with a special emphasis on epilepsy.

Dr. Wolf provides an overview of drug-resistant epilepsy (DRE), outlines the risks of under or untreated seizures, including sudden unexpected death in epilepsy (SUDEP), and talks about treatment options beyond medication.

Additional Resources:

Epilepsy/seizure disorders in TSC: https://www.tscalliance.org/understanding-tsc/clinical-manifestations/brain-neurological-function/epilepsy-seizure-disorders/
Child Neurology Foundation Epilepsy Education Hub: https://www.childneurologyfoundation.org/epilepsy-education-hub/?gad_source=1&gclid=Cj0KCQiAo5u6BhDJARIsAAVoDWsnleWiozC7siAXUMT7DaEkFtvnH328mEN4WprD595yT7t8IXDsGQEaAozfEALw_wcB
Epilepsy Foundation: https://www.epilepsy.com/

LivaNova sponsored this episode. The opinions expressed are those of our guest speakers and host individually and do not reflect the policies or positions of LivaNova. The following content is for informational purposes only. It is not medical advice and is not intended to recommend or suggest a course of treatment or treatment options. Be sure to talk to your doctor about your symptoms and conditions.

Episode 46: Understanding drug resistant epilepsy and treatment options

October 27, 2023Episodesbrain surgery, drug resistant epilepsy, epilepsy, epilepsy medication, epilepsy surgery, ketogenic diet, medications, neuromodulation, refractory epilepsy, seizures, TSC, TSC Alliance, tuberous sclerosis, tuberous sclerosis complex, vagus nerve stimulation, VNStsc-now

Podcast: Play in new window | Download

In this episode of TSC Now, host Dan Klein interviews Karen Keough, MD, a child neurologist at Child Neurology Consultants of Austin. Dr. Keough defines drug resistant epilepsy (DRE), explains how lack of seizure control can impact someone’s quality of life and shares some treatment options beyond medication, including surgery, dietary therapies and neuromodulation devices. This episode is sponsored by LivaNova.

Additional resources

TSC Alliance: https://www.tscalliance.org/about-tsc/signs-and-symptoms-of-tsc/brain-and-neurological-function/epilepsy-and-seizure-disorders/
Epilepsy Foundation of America: https://www.epilepsy.com/
International League Against Epilepsy: https://www.ilae.org/
Child Neurology Consultants of Austin: https://www.childneurotx.com/conditions/epilepsy-seizures/

This episode is sponsored by:

Episode 43: The TSC-STEPS Trial

March 15, 2023Episodesclinical research, clinical trials, epilepsy, epilepsy medication, epilepsy research, medical research, medications, Newborn Screening, rare disease, seizures, TAND, TSC, TSC Alliance, TSC research, tuberous sclerosis, tuberous sclerosis complextsc-now

Podcast: Play in new window | Download

In this episode of TSC Now, host Dan Klein dives deep on a new clinical trial in tuberous sclerosis complex (TSC) called TSC-STEPS. TSC-STEPS is a study to learn more about a drug known as Sirolimus and determine if it can prevent seizures and epilepsy in children diagnosed with TSC. The study is currently enrolling infants diagnosed with TSC who are at risk of developing epilepsy. \

Dan interviews Darcy Krueger, MD, PhD, Director of the TSC Center of Excellence at Cincinnati Children’s Hospital and member of the TSC Alliance Board of Directors (0:59). Dr. Krueger provides an overview of the trial, the eligibility requirements, risks and benefits to participation, and what participation entails for families in terms of site visits and tests. He also discusses how the trial builds off findings of earlier intervention trials and may be part of a greater shift in the paradigm of care for those with TSC. Finally, he provides information about other upcoming and ongoing trials looking for older participants, and encourages everyone listening to help raise awareness of these important trials to help recruit participants and move research forward.

Resources and Links

Learn more about the TSC-STEPS trial: https://tscsteps.org/
Learn more about the MILED trial: https://www.thelamfoundation.org/MILED
Learn more about the Developmental Synaptopathies Consortium: https://www1.rarediseasesnetwork.org/cms/dsc
Learn more about the Bcureful Travel Fund at the TSC Alliance: https://www.tscalliance.org/individuals-families/bcureful-travel-lodging-assistance/
Learn more about clinical trial participation: https://www.tscalliance.org/individuals-families/tsc-clinical-trials/
Check out TSC clinical trials that are currently recruiting: https://trials.tscalliance.org/

Episode 42: Understanding Seizure Clusters

February 3, 2023Episodesepilepsy, epilepsy medication, epilepsy research, rescue medications, seizure action plans, seizure clusters, seizure medication, seizures, status epilepticus, TSC, TSC Alliance, tuberous sclerosis, tuberous sclerosis complextsc-now

Podcast: Play in new window | Download

In the first episode of TSC Now in 2023, host Dan Klein recognizes International Epilepsy Day (February 13, 2023) and Seizure Action Plan Awareness Week (February 13-20, 2023) by learning about seizure clusters, which are episodes of frequent seizure activity that are distinct from a person’s usual seizure pattern. Seizure clusters may also be called acute repetitive seizures, serial seizures, crescendo seizures or seizure flurries and in every case they are an emergency that often require rescue medication, calling for emergency response or both.

Dan is joined by James Wheless, MD, (01:33) Director of the Neuroscience Institute and Comprehensive Epilepsy Program and Co-Director of the TSC Center of Excellence at Le Bonheur Children’s Hospital, and Professor and Chief of Pediatric Neurology at University of Tennessee Health Science Center. Dr. Wheless describes what seizure clusters are, why they are a medical emergency and how new rescue medications can provide peace of mind to people who suffer from seizure clusters. He also discusses the importance of creating a seizure action plan and how to best implement and refine that plan to make sure it is working. Finally, he emphasizes the importance for parents to meet with their neurologist as soon as they notice irregular seizure activity and to not hesitate to use rescue medication when their loved one experiences an irregular change in the frequency or severity of their seizures.

Resources and Links

Learn more about International Epilepsy Day: https://internationalepilepsyday.org/
Learn more about Seizure Action Plans and Seizure Action Plan Awareness Week: https://seizureactionplans.org/

This episode is sponsored by:

Episode 33: Noema, Basimglurant and a New Clinical Trial for Seizures in TSC

February 7, 2022Uncategorizedclinical trials, epilepsy, epilepsy medication, epilepsy research, medical research, medications, preclinical research, seizures, TSC, TSC Alliance, TSC research, tuberous sclerosis complextsc-now

Podcast: Play in new window | Download

In a very special early episode of TSC Now, host Dan Klein recognizes International #EpilepsyDay and the kickoff of the second annual Seizure Action Plan Awareness Week. In November 2020, a collaboration of three non-profit organizations, the TSC Alliance, Dravet Syndrome Foundation and Lennox-Gastaut Syndrome (LGS) Foundation, launched the Seizure Action Plan (SAP) Coalition to educate people with epilepsy, their caregivers and healthcare professionals about seizure emergency rescue protocols and the importance of personalized seizure action plans. As part of this effort the group is recognizing Seizure Action Plan Awareness Week (#SAPAW2022) to coincide with International Epilepsy Awareness Day on February 14.

This month’s episode is sponsored by Noema Pharma and explores their clinical trial to treat seizures common in TSC. A Swiss biotech company, Noema, is investigating a novel substance which has shown some positive effects in laboratory models related to tuberous sclerosis complex (TSC). The substance is called basimglurant, and it affects the activity of glutamate, an important molecule used by many neurons to communicate with other neurons in the brain, by acting on a receptor for glutamate called mGluR5. The company is setting up clinical trials to test whether the effect seen in the laboratory may also be seen in people.

First, to learn more about basimglurant and preclinical experiments underpinning the upcoming clinical trial, Dan spoke to Ype Elgersma, Professor of Molecular Neuroscience, Head of Research in the Department of Clinical Genetics, and Director of the ENCORE Expertise Center for Neurodevelopment Disorders at the Erasmus Medical Center In The Netherlands; and John Kemp, Former Chief Scientific Officer at Noema (02:28). They share what metabotropic glutamate receptor 5, or mGluR5, is and how increased activity at mGluR5 may lead to epilepsy; how negative modulators of this overactivity may be used as a treatment for epilepsy in TSC, and how Dr. Mustafa Sahin of Harvard Medical School tested this hypothesis in TSC mouse models. Findings from this study was published in 2018 in Neuropsychopharmacology.

Next, Dan spoke to Ali Mostajelean, MD, Associate Professor of Neurology, Director of the Epilepsy Service and Tuberous Sclerosis Clinic at UCSF Benioff Children’s Hospital; and George Garibaldi, Chief Medical Officer at Noema (07:55). They shared how Noema is using the findings in animal models as justification for a clinical trial and share how clinical studies using basimglurant for depression and Fragile X showed that the compound was safe in humans, albeit not as effective as researchers thought it would be in those disease states.

Finally, Dan spoke with Renata Lazarova, VP of Development, Pediatric Programs at Noema, and Steve Roberds, PhD, Chief Scientific Officer of the TSC Alliance (10:55), to learn what the clinical trial looks like, who can enroll, how Noema will determine whether the drug is efficacious and safe, and where people can find more information. Steve also talked about our partnership with Noema and how they worked with the TSC Alliance early on to solicit feedback from the TSC community and design a trial that both meets the needs of those with TSC and considers the quality of life of those participating.

Noema’s clinical study with their negative modulator of mGluR5 is currently participants across the US, Russia, Ukraine, Israel and Australia. For more information including the list of sites participating in the study, please contact Jo Anne Nakagawa at jnakagawa@tscalliance.org or (301) 562-9890.

Resources and Links
Learn more about International Epilepsy Day: https://internationalepilepsyday.org/
Learn more about the Seizure Action Plan Coalition and #SAPAW2022: https://seizureactionplans.org/
Learn more about epilepsy in TSC: https://www.tscalliance.org/about-tsc/signs-and-symptoms-of-tsc/brain-and-neurological-function/epilepsy-and-seizure-disorders/
Read an abstract of Dr. Sahin’s research looking at mGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis Complex: https://www.nature.com/npp/about?gclid=Cj0KCQiA34OBBhCcARIsAG32uvPcCBYuxzzlON-Xe9EikeYJD6XNNl8TDElaFiONa-02BSWFUv4w2voaAk6REALw_wcB

This episode is sponsored by:

Learn more about Noema Pharma: https://noemapharma.com/

Episode 23: Autism Spectrum Disorder in TSC and TACERN

May 1, 2021Episodesautism, autism spectrum disorder, clinical research, clinical trials, epilepsy medication, epilepsy research, infantile spasms, medical research, medications, neuropsychiatric disorder, rare disease, TAND, TS Alliance, TSC, TSC research, tsc-associated neuropsychiatric disorders, tuberous sclerosis, Tuberous Sclerosis Alliance, tuberous sclerosis complextsc-now

Podcast: Play in new window | Download

In Episode 23 of TSC Now, host Dan Klein recognizes World Autism Month and Autism Acceptance Month by learning more about autism spectrum disorder (ASD) in tuberous sclerosis complex (TSC). ASD occurs in nearly 50% of children with TSC, significantly higher the rate in the general population (roughly 1% worldwide). Additionally, there is a very clear link between ASD and cognitive impairment in TSC.

To better understand the connection between autism and TSC, and how ongoing research can help expand our knowledge of autism not just in TSC, but more generally, Dan spoke to Mustafa Sahin, MD, PhD, (02:11) Director of both the Translational Neuroscience Center and the Multi-Disciplinary Tuberous Sclerosis Program at Boston Children’s Hospital, and Professor of Neurology at Harvard Medical School. Dr. Sahin is one of the Principal Investigators of the TSC Autism Center of Excellence Research Network, otherwise known as TACERN. TACERN is a coalition of five research hospitals: Boston Children’s Hospital, Cincinnati Children’s Hospital Medical Center, University of Alabama at Birmingham, University of California at Los Angeles and University of Texas at Houston. The group was formed in 2012 and received a grant from the NIH to better understand autism in TSC and to identify potential biomarkers that could predict what children were at higher risk of cognitive manifestations. From that initial grant 80 papers have been published on a wide range of discoveries in TSC. Dr. Sahin shares some of the discoveries from the last decade, how discoveries made in autism in TSC have wider implications for autism in general, the current progress on identifying biomarkers, and what questions remain.

Finally, we are officially two weeks away from the Step Forward to Cure TSC^® Global Virtual Walk-Run-Ride on May 15 and 16, coinciding with TSC Global Awareness Day. This historic, world-wide event will bring together thousands of people from across the globe, all working together to champion the Tuberous Sclerosis Alliance’s efforts to fund groundbreaking research, offer critically needed support programs and increase awareness. Our goal is to raise $700,000 toward that mission, and there is still time for you to donate, register and fundraise to help us hit that goal. However you participate, your support makes a tangible difference in the lives of everyone with TSC. Learn the many ways you can get involved at www.stepforwardtocuretsc.org. Thank you to both the National and Local sponsors for championing this amazing event!

National Sponsors

Local Sponsors

Resources and Links

Learn the basics of autism in tuberous sclerosis complex: https://www.tsalliance.org/about-tsc/signs-and-symptoms-of-tsc/brain-and-neurological-function/tsc-and-autism-spectrum-disorders/
Learn more about World Autism Month: https://www.autismspeaks.org/world-autism-month
Learn more about Autism Acceptance Month: https://www.autism-society.org/get-involved/national-autism-awareness-month/
Learn more about TACERN: http://tscstudy.com/
Learn more about the Developmental Synaptopathies Consortium: https://www.rarediseasesnetwork.org/cms/dsc/
Learn more about the current studies going on at the Sahin lab: http://sahin-lab.org/
Re-Watch the 2021 E-Webinar TAND: Early Interventions featuring Drs. Shafali Jeste and Connie Kasari: https://youtu.be/BlTmJ4qUoMk

Episode 22: Overcoming Hurdles with Health Plans and Specialty Pharmacies

March 30, 2021Episodesbehaviors, COVID-19, epilepsy, epilepsy medication, insurance issues, medication access, medications, specialty pharmacies, TS Alliance, TSC, tuberous sclerosis, Tuberous Sclerosis Alliance, tuberous sclerosis complextsc-now

Podcast: Play in new window | Download

In Episode 22 of TSC Now, host Dan Klein explores overcoming hurdles in healthcare, specifically to help parents/caregivers and individuals with tuberous sclerosis complex (TSC) navigate issues with access to medications, changes to their health plans and how to best communicate with specialty pharmacies. This episode is sponsored by Greenwich Biosciences.

Disclaimer: Greenwich Biosciences utilized Precision Value and Health’s services to gather and respond to the questions being discussed on this podcast. The opinions expressed are those of the speakers individually based on their experience and do not reflect the policies or positions of the speakers’ employers or of Greenwich Biosciences. The following content is for informational purposes only and does not guarantee access or coverage of any product.

First, to provide some context on what access challenges can be like for individuals and families, Dan talked to Shelly Meitzler (01:40), TS Alliance Regional Program Manager East and mom to Ashlin and Mason with TSC. Shelly shares about a recent challenging experience refilling a prescription for Ashlin earlier this year. She talks about where she hit roadblocks, how she felt navigating the insurance and pharmacy system, and how she ultimately got resolution. Her story highlights several common hurdles experienced by many families, including problems when switching insurance plans, not knowing when a prior authorization is required, trying to figure out who your care team is at your pharmacy, and finally dealing with a retail pharmacy versus a specialty pharmacy.

Then, to tackle common questions, some of which were mentioned in Shelly’s story, Dan speaks to two former payers, Hetty Lima and Kellie Rademacher from Precision Value and Health (17:44). Building off of their extensive pharmacy knowledge, Hetty and Kellie answer a number of questions members have when dealing with access issues, such as:

What do I need to do if my health plan changes?
What do I do when my medication is no longer covered by my insurance plan?
How do I navigate having two different health plans?
How do I know when a medication requires a prior authorization, step therapy, or has a quantity limit or any other type of rule or edit that could impact access?
Where can I find available resources if I need emergency access to my medications?

This conversation builds off of an E-Webinar from earlier this year, Overcoming Hurdles: Insurance, Scripts and Specialty Pharmacy, where Jeff Krol, VP of Market Access & Payer Strategy at Greenwich Biosciences, and Ashley Pounders, MSN, FNP, TS Alliance Director of Medical Affairs, provide useful tips on navigating the complex prescription insurance coverage, scripts and specialty pharmacy. We encourage you to re-watch the recording for more information and resources on this topic.

Finally, if you are at risk of running out of a medication for you or your loved one and need assistance, please contact us on our emergency line: (240) 463-7250. That number is available 9 AM to 9 PM Eastern and someone from our team can help.

Resources and Links

Overcoming Hurdles: Insurance, Scripts and Specialty Pharmacy E-Webinar: https://youtu.be/Opik3h7Z4ek
- Download the slides from the presentation: http://www.tsalliance.org/wp-content/uploads/2021/02/GRNEPXLA20011_002-TS-Alliance-Webinar-Presentation-FINAL.pdf

This episode was sponsored by:

Episode 19: Infantile Spasms Awareness Week (#ISAW2020)

December 8, 2020EpisodesCOVID-19, epilepsy, epilepsy medication, infantile spasms, Infantile Spasms Action Network, Infantile Spasms Awareness Week, IS, seizures, TS Alliance, TSCtsc-now

Podcast: Play in new window | Download

In a very special early edition of TSC Now, host Dan Klein explores the topic of infantile spasms (IS) as Infantile Spasms Awareness Week (ISAW), held annually December 1-7 to raise awareness of IS with both parents/caregivers and frontline physicians, comes to a close. To learn more about infantile spasms go to www.infantilespasms.org.

First, Dan talks to Kelly Knupp, MD, Associate Professor of Pediatrics and Neurology at the University of Colorado Anschutz Medical Campus and member of Infantile Spasms Action Network (ISAN) (01:23). She discusses what infantile spasms are, what they look like and are sometimes misdiagnosed as, and why they are so serious to the cognitive development of babies. She also explains what tests need to be done to confirm a diagnosis, what first line treatments are available, and why early intervention is so important. Finally, she offers advice to parents who suspect their child might be having spasms, and urges all parents who are concerned to first take a video of the strange behavior to share with their doctor and then don’t delay in seeking care despite the ongoing COVID-19 pandemic.

Then, Dan talks to Ashley Callahan of St. Augustine, Florida (14:53). In June when her daughter Kaylee was 4 months old, Ashely noticed Kaylee making strange repetitive eye movements, which prompted a trip to the emergency room despite the COVID-19 pandemic and eventually a diagnosis of infantile spasms. Ashley shares what led to the decision to take Kaylee to the emergency room, what it was like getting a diagnosis of IS, and how she has found support through groups online. She also shares her advice for other parents who may be worried about their child and encourages them to trust their instincts.

Throughout Infantile Spasms Awareness Week, the TS Alliance and other ISAN partners have made a coordinated effort to develop resources for families and to generate coverage of this important initiative. Below are some links to some of these resources and coverage of #ISAW2020. Our deepest thanks to everyone who helped raise awareness of infantile spasms this year.

Resources and Links

TS Alliance President and CEO Kari Rosbeck joined Dr. Rahat Sayyad, host of the DoctorMommySpeaks podcast, to talk about infantile Spasms: https://podcasts.apple.com/us/podcast/ep-16-how-to-identify-infantile-spasms-take-action/id1524071289?i=1000500499737
Kari also spoke to Dr. Elliot Berlin, host of the Informed Pregnancy Podcast: https://www.informedpregnancy.com/listen/episode/3a869a0f/infantile-spasms-kari-rosbeck
Dr. Martina Bebin, MD, MPA, Professor of Neurology and Pediatrics at the University of Alabama at Birmingham Epilepsy Center, discussed the challenges of IS in an interview with NeurologyLive: https://www.neurologylive.com/view/martina-bebin-md-mpa-challenges-associated-with-infantile-spasms
- A written version of the interview can be found here: https://www.neurologylive.com/view/neurovoices-martina-bebin-md-mpa-on-infantile-spasms-awareness
Dr. Shaun Hussein, MD, MS, Director of the UCLA Infantile Spasms Program, gave an interview with Babygaga on how to identify infantile spasms: https://www.babygaga.com/interview-dr-shaun-hussain-infantile-spasms/
The Callahan family shared their story with the St. Augustine Register, Newsweek and St. Augustine Moms (full links below)
- St. Augustine Register: https://www.staugustine.com/story/news/local/2020/11/26/st-augustine-family-deals-infantile-spasms/6407392002/
- Newsweek: https://www.newsweek.com/my-baby-had-medical-emergency-during-covid-1551428
- St. Augustine Moms: https://staugustine.momcollective.com/health-wellness/my-infant-experienced-a-medical-emergency-during-covid-infantile-spasms/
The Mosco family shared the story of their daughter Hanna’s IS diagnosis in the San Diego Union-Tribune: https://www.sandiegouniontribune.com/opinion/commentary/story/2020-12-07/commentary-dont-avoid-check-ups-or-the-er-becuase-of-coronavirus-our-baby
Finally, the Infantile Spasms Awareness Network created a short video to help parents know the signs on IS: https://youtu.be/kRt8muFfUQo
- A Spanish version is also available for sharing: https://youtu.be/KwnuYOureUw

Episode 8: Excerpts from AES and the Current State of Epilepsy Research

December 16, 2019EpisodesAmerican Epilepsy Society, antiepileptic medication, biosamples, epilepsy, epilepsy medication, epilepsy research, seizure control, seizure diaries, seizures, TS Alliance, TSC, tuberous sclerosis, Tuberous Sclerosis Alliance, tuberous sclerosis complextsc-now

Podcast: Play in new window | Download

In the eighth episode of TSC Now, host Dan Klein catches up with TS Alliance partners at the annual American Epilepsy Society Meeting (AES), the largest gathering on epilepsy in the world, which was held December 6-10 in Baltimore. Seizures remain one of the most common neurological features of TSC, occurring in 85% of individuals with TSC and more than 50% of individuals with TSC who have epilepsy will not respond to standard antiepileptic medications and have intractable epilepsy. Therefore, this meeting was a good opportunity to explore the current state of epilepsy research, what gaps still exist and what’s on the horizon. Continue reading Episode 8: Excerpts from AES and the Current State of Epilepsy Research →

Episode 7: Common Parent/Caregiver Challenges and Advocating for Your Health

November 16, 2019Episodesepilepsy, epilepsy medication, healthcare, Lennox-Gastaut Syndrome, patient advocacy, rare disease, seizures, transition, TS Alliance, TSC, tuberous sclerosis, Tuberous Sclerosis Alliance, tuberous sclerosis complextsc-now

Podcast: Play in new window | Download

In the seventh episode of TSC Now, host Dan Klein explores common challenges parents, caregivers and those affected by tuberous sclerosis complex (TSC) face when managing their health and seeking care from physicians.

First, he has a conversation with Paul Mullin, MD, Director of Neurology and Epilepsy at Medical Associates of the Hudson Valley (01:22). They discuss the results of a survey conducted by Aquestive Therapeutics on some of the most common challenges parents face when trying to administer medication to children with epilepsy and how new technology can help alleviate some of these challenges. They also talk about what parents and caregivers can do to be proactive in addressing seizures and working with their doctor. Dr. Mullin also shares several online resources where parents can get accurate and reliable information and advice, including the Epilepsy Foundation, the National Organization for Rare Disorders (NORD), the National Institute of Neurological Disorders and Stroke (NINDS) and the LGS Foundation.

Next, Dan talks to Peter Crino, MD, PhD, Professor and Chair of the Department of Neurology at the University of Maryland School of Medicine, Director of the TSC Center of Maryland, and a member of the TS Alliance Board of Directors (20:12). We discuss the process of transitioning a patient with TSC from pediatric to adult care, some of the challenges associated with that transition, and how parents and those affected can start preparing to mitigate those challenges. We also talked about how adults with TSC can best manage their care and Dr. Crino emphasizes the importance of following the Consensus Guidelines for Diagnosis, Surveillance and Management of TSC to ensure that different manifestations of the disease are being monitored and managed appropriately throughout one’s lifetime. Finally, we discuss the role telemedicine may play in expanding access to TSC experts.

This episode was sponsored by: